Drug discovery and
development is offered as a concentration within the professional science
master's program described under Business and Science 137. The objective of the master of business and science
degree with a concentration in drug discovery and development is to provide
broad-based training for students in the area of drug discovery, drug
development, regulatory affairs, and clinical trials management. Students will
learn about the workings of the pharmaceutical development process and will
acquire analytical and communication skills suitable for managerial and staff
positions in laboratory and clinical research, clinical trials, contract
research organizations, federal agencies for regulatory affairs (e.g., the Food
and Drug Administration), and pharmaceutical marketing.
All students in the drug discovery and development
concentration must take the following courses: (five courses total, 15 credits):
16:137:510 Drug Development from Concept to
Market (3)
16:137:511 Drug Discovery through Preclinical
Development (3)
16:115:511/512 Molecular
Biology and Biochemistry (3) or 16:148:514 Molecular Biology of
Cells (3)
Two courses from the following:16:137:580
Practical Aspects of Clinical Trial Design/Conduct (3)
16:137:582 Fundamentals of Regulatory Affairs (3)
16:137:581 Statistics in Clinical and Translational
Research (3)
Course descriptions and electives can be found at http://mbs.rutgers.edu.
Concentration Coordinator:
Dr. Matt Sills
msills@docs.rutgers.edu
Programs, Faculty, and Courses 
